Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality.

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Zhou, F; Liu, Y-M; Xie, J; Li, H; Lei, F; Yang, H; Qin, J-J; Cai, J; Zhang, X-J; Wu, B; Xia, M; Xiang, D; Yang, C; Ma, X; Xu, Q; Lu, Z; Lu, H; Xia, X; Wang, D; Liao, X; Peng, G; Yang, J; Huang, X; Zhang, B-H; Yuan, Y; Wei, X; Liu, PP; Wang, Y; Zhang, P; She, Z-G; Xia, J; Li, H

Published Date

  • August 2020

Published In

Volume / Issue

  • 76 / 2

Start / End Page

  • e15 - e17

PubMed ID

  • 32493070

Electronic International Standard Serial Number (EISSN)

  • 1524-4563

Digital Object Identifier (DOI)

  • 10.1161/HYPERTENSIONAHA.120.15622


  • eng

Conference Location

  • United States